Centene/$CNC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Centene
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
Ticker
$CNC
Sector
Primary listing
NYSE
Industry
Health Care Providers & Services
Headquarters
Employees
60,500
ISIN
US15135B1017
Website
Centene Metrics
BasicAdvanced
$16B
4.92
$6.72
0.44
-
Price and volume
Market cap
$16B
Beta
0.44
52-week high
$79.19
52-week low
$31.78
Average daily volume
10M
Financial strength
Current ratio
1.112
Quick ratio
1.068
Long term debt to equity
65.341
Total debt to equity
65.384
Interest coverage (TTM)
7.55%
Profitability
EBITDA (TTM)
6,484
Gross margin (TTM)
14.29%
Net profit margin (TTM)
2.25%
Operating margin (TTM)
3.42%
Effective tax rate (TTM)
23.84%
Revenue per employee (TTM)
$2,530,000
Management effectiveness
Return on assets (TTM)
3.86%
Return on equity (TTM)
12.53%
Valuation
Price to earnings (TTM)
4.924
Price to revenue (TTM)
0.111
Price to book
0.59
Price to tangible book (TTM)
3.21
Price to free cash flow (TTM)
11.357
Free cash flow yield (TTM)
8.81%
Free cash flow per share (TTM)
291.37%
Growth
Revenue change (TTM)
7.15%
Earnings per share change (TTM)
33.19%
3-year revenue growth (CAGR)
7.27%
10-year revenue growth (CAGR)
24.52%
3-year earnings per share growth (CAGR)
38.47%
10-year earnings per share growth (CAGR)
18.42%
What the Analysts think about Centene
Analyst ratings (Buy, Hold, Sell) for Centene stock.
Bulls say / Bears say
Centene's commercial insurance segment experienced a 35% increase in memberships, leading to a 48% rise in revenue to $7.75 billion in Q1 2024, indicating strong growth potential in this area. (reuters.com)
Analysts have set an average 12-month price target of $78 for Centene, suggesting a potential upside of approximately 33% from its current trading price. (wallstrank.com)
Centene's forward P/E ratio of 7.08 indicates that the stock is priced favorably compared to its future earnings potential, making it attractive from a value perspective. (directorstalkinterviews.com)
On July 2, 2025, Centene's stock plummeted nearly 40% after the company withdrew its financial guidance due to unexpectedly high healthcare costs, particularly in its Obamacare and Medicaid programs. (ft.com)
Centene's total expenses rose by 1% in Q2 2023 due to higher medical costs, which can trim its margins and impact profitability. (finance.yahoo.com)
The company's return on equity (ROE) of 14.2% is below the industry average of 23.2%, indicating less efficient utilization of shareholders' funds. (finance.yahoo.com)
Data summarised monthly by Lightyear AI. Last updated on 7 Jul 2025.
Centene Financial Performance
Revenues and expenses
Centene Earnings Performance
Company profitability
Centene News
AllArticlesVideos
CNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Centene Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewsWire·5 hours ago
CNC BREAKING CLASS ACTION: Centene Corporation has been Sued for Securities Fraud; Investors with Losses are Notified to Contact BFA Law by September 8 Court Deadline (NYSE:CNC)
GlobeNewsWire·6 hours ago
Law Offices of Howard G. Smith Encourages Centene Corporation (CNC) Investors To Inquire About Securities Fraud Class Action
Business Wire·7 hours ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Centene stock?
Centene (CNC) has a market cap of $16B as of July 11, 2025.
What is the P/E ratio for Centene stock?
The price to earnings (P/E) ratio for Centene (CNC) stock is 4.92 as of July 11, 2025.
Does Centene stock pay dividends?
No, Centene (CNC) stock does not pay dividends to its shareholders as of July 11, 2025.
When is the next Centene dividend payment date?
Centene (CNC) stock does not pay dividends to its shareholders.
What is the beta indicator for Centene?
Centene (CNC) has a beta rating of 0.44. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.